Back to Evidence
Primary experimental recordNegative / threshold

PMC13133793::ACT044559

LCKLSL

Evidence text

Paper-level observation

ERG recordings... revealed transient reductions in a-wave and b-wave amplitudes on day 3 post-intervention. However, these functional changes showed no statistical significance (p>0.05) (Figure 2D, E, and F).
textConfidence: medium

Assay observation

Activity
Toxicity
Subtype
General Toxic
Measure
other
Comparator
>
Raw observation
transient reductions... no statistical significance (p>0.05)
Normalized measurement
>0.05
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Mus musculus
Assay method
Not reported by source
Sequence
LCKLSL
Standardization
ready simple

Source publication

Study on the Role of Short Peptide LCKLSL Targeting ANXA2 in Retinal Neovascularization.

In Vivo · 2026

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.